Center-Authored Papers

Filters: Author is Yamamoto, Tori N  [Clear All Filters]
2010
Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang W-C, Greisman HA et al..  2010.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.. Blood. 116(22):4532-41. Abstract
2011
Anderson LD, Cook DR, Yamamoto TN, Berger C, Maloney DG, Riddell SR.  2011.  Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.. Cancer immunology, immunotherapy : CII. 60(7):985-97. Abstract
2012
Stemberger C, Dreher S, Tschulik C, Piossek C, Bet J, Yamamoto TN, Schiemann M, Neuenhahn M, Martin K, Schlapschy M et al..  2012.  Novel serial positive enrichment technology enables clinical multiparameter cell sorting.. PloS one. 7(4):e35798. Abstract
Jing L, Haas J, Chong TM, Bruckner JJ, Dann GC, Dong L, Marshak JO, McClurkan CL, Yamamoto TN, Bailer SM et al..  2012.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.. The Journal of clinical investigation. 122(2):654-673. Abstract
Terakura S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR.  2012.  Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.. Blood. 119(1):72-82. Abstract
2013
McGoldrick SM, Bleakley ME, Guerrero A, Turtle CJ, Yamamoto TN, Pereira SE, Delaney CS, Riddell SR.  2013.  Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.. Blood. 121(14):2796-803. Abstract